Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NutraMax

This article was originally published in The Tan Sheet

Executive Summary

OTC private labeler faces threatened delisting of its common stock by NASDAQ for delayed reporting of third quarter and nine-month financial results for the periods ended July 3. NASDAQ informed the Gloucester, Mass.-based company it must satisfy continued listing criteria. Any delisting has been stayed pending a NutraMax-requested hearing, expected to occur in the next several weeks. The company says a physical inventory and additional accounting procedures have delayed reporting of its results (1"The Tan Sheet" Aug. 30, p. 14)
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS090285

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel